I may well buy some Venus shares, with eyes wide open that it could be a pump and dump, and take advantage of what we've seen here.I'm not condoning their behaviour, but I may as well benefit from it.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%